EVs driving India's Next Growth Story: MoS (See 'Corp Brief') Meditation is scientific tool for stress management and neuroplasticity: Experts (See 'Corp Brief') Misc - Directors of company under winding up are statutorily bound under Section 454 of Companies Act, to make full and accurate disclosure of assets: HC (See 'Legal Desk') Mandaviya leads 1st Anniversary Celebrations of Fit India Sundays on Cycle in Puducherry (See 'Corp Brief') MoHUA launches 10th Swachh Survekshan (See 'Corp Brief') Misc - Once CIRP is initiated, all claims against corporate debtor must be routed through insolvency process: HC (See 'Legal Desk') Centre releases grants of Rs 94 Crores for PRIs in Uttarakhand (See 'Corp Brief') New Logo for RRBs signifying single and unified brand identity unveiled (See 'Corp Brief') PMVBRY aims to incentivise creation of over 3.5 crore jobs over 2 years (See 'Corp Brief') IPR - Pharmaceutical guidelines illustrate that if combination of two prior art documents fails to provide result as claimed in invention in question, then teaching of prior art documents is considered to be teaching away: HC (See 'Legal Desk') Ministry of Parliamentary Affairs transforming functioning into paperless ecosystem (See 'Corp Brief') Scindia chairs review meeting on Matabari Tourism Circuit Development in Tripura (See 'Corp Brief') IPR - If Novartis had consciously waived its right to cross-examination by electing to file rebuttal evidence, there are no valid grounds to challenge Controller's order: HC (See 'Legal Desk') WHO Global Summit on Traditional Medicine Commences in New Delhi (See 'Corp Brief') MoS delivers national statement at UN on outcomes of World Summit on the Information Society (See 'Corp Brief') PM MITRA Parks anchored in 5F vision generating huge investment interest (See 'Corp Brief') IPR - While assessing 'prior art', mere similarity is insufficient and visual distinction matters, and for prior art to invalidate design, it must be clearly established and comparable in relevant features: HC (See 'Legal Desk') Steps taken to strengthen security of cyber ecosystem (See 'Corp Brief') ICG Ship Sarthak makes Strategic Port Call at Chabahar (See 'Corp Brief') IPR - On being satisfied that brand or mark has acquired status which is well known, there ought to be order directing that no individuals should be allowed to register UPI Ids or VPAs with said brand names: HC (See 'Legal Desk') CCI okays acquisition of paper & pulp manufacturing business of ABREL by ITC Ltd (See 'Corp Brief') CCI okays acquisition of equity stake in Logisteed Holdings, Ltd. by Japan Post Co., Ltd. (See 'Corp Brief') CCI nod to proposed combination involving acquisition of minority shareholding in DCX Global Limited by Coinbase Global Inc. (See 'Corp Brief') IBC - Compromise between bank and co-guarantor did not extinguish liability of other guarantors, who issued separate, enforceable undertakings: HC (See 'Legal Desk')

Print

Pharmaceuticals & Medical Devices Bureau has partnered to open Jan Aushadhi Kendras

Published: Dec 11, 2024

By TIOLCorplaws News Service

NEW DELHI, DEC 11, 2024: TO increase access to medicines in rural areas, the Pharmaceuticals & Medical Devices Bureau of India, the implementing agency of PMBJP has partnered with the Cooperative sector to open Jan Aushadhi Kendras through Primary Agriculture Cooperative Societies (PACS). Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS.

The government launched Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) under which Jan Aushadhi Kendras (JAKs) are opened by inviting applications from individual entrepreneurs, NGOs, Societies, Trusts, Firms, and Private Companies etc. While opening these Kendras, 1 km distance is maintained between two Kendras. Online applications have been invited from all districts through the website www.janaushadhi.gov.in. This process facilitates opening of Jan Aushadhi Kendras (JAKs) at the block as well as at the district level. There is no State/UT-wise target for opening of new JAKs.

Jan Aushadhi medicines are being supplied to Central Government Health Scheme dispensaries, various AIIMS, Hospitals, etc. based on their demand. All JAK owners are eligible for an incentive @ 20% of monthly purchases made by them, subject to a ceiling of Rs. 20,000/- per month. In addition, a one-time incentive of Rs. 2.00 lakh is provided to the JAKs opened in North-Eastern States, Himalayan areas, Island territories, and areas mentioned as aspirational districts by NITI Aayog or opened by women entrepreneurs, ex-servicemen, Divyang, SC & ST in the form of support towards furniture, computers, refrigerators, and other fixtures. For operational support, there are State-wise Marketing Officers who support applicants in obtaining Drug licenses and supply of medicines to JAKs by the distributor and warehouse network of Jan Aushadhi.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in a written reply to a question yesterday.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.